Mohs Surgery – Friday Pop Quiz 8/16/2024
A 68-year-old man presents for a full-body skin examination 2 days after undergoing Mohs micrographic surgery for a squamous cell carcinoma of the left helix. The patient has a second appointment with the Mohs surgeon in 20 days. However, the patient is extremely frustrated with the appearance of his ear and wants alternative therapies for his ear. Which of the following is the most appropriat …
JDD Buzz Series | DermTok: Who’s Talking Sun?
sun protectionTikTok is a source of beauty and skin health information for the masses. Yet much of the content is not produced by board-certified dermatologists or even other healthcare professionals. So who’s creating TikTok content about sun protection and skin cancer? Does any of this content address skin of color? Those are the questions a new cross-sectional analysis published in the July Journal of Drug …
sun protection
Ritlecitinib Therapeutic Cheat Sheet
RitlecitinibAlopecia areata (AA) is a nonscarring alopecia driven by autoreactive cytotoxic CD8 T cells against hair follicle antigens. With an unpredictable clinical course, which can include alopecia totalis and universalis, AA can be debilitating to patients’ quality of life. Historically, glucocorticosteroids, cyclosporine, methotrexate, and azathioprine were used off-label for non-targeted immunosuppre …
Ritlecitinib
JDD August 2024 Issue Highlights
PSORIASIS In the August edition of the Journal of Drugs in Dermatology (JDD), we turn our focus to psoriasis, one of the most challenging and impactful dermatological conditions. This month’s Editor's Picks showcase a series of in-depth studies and expert discussions that explore the latest advancements in psoriasis treatment, real-world effectiveness, and the broader implications of the disease …
PSORIASIS